Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence

Background: Success has been reported in PD-1/PD-L1 blockade via pembrolizumab, atezolizumab, or avelumab monotherapy in manifold malignancies including metastatic breast cancer. Due to lack of large-scale study, here we present interim analyses to evaluate the safety and efficacy of these promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Yihang, Zhang, Lin, Wang, Zhongzhao, Kong, Xiangyi, Zhai, Jie, Fang, Yi, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276035/
https://www.ncbi.nlm.nih.gov/pubmed/34267656
http://dx.doi.org/10.3389/fphar.2021.653521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276035/
https://www.ncbi.nlm.nih.gov/pubmed/34267656
http://dx.doi.org/10.3389/fphar.2021.653521

Ejemplares similares